Intellia Therapeutics, Inc. (NTLA): SCHEDULE 13G/A filed Feb 11, 2026

Form type

SCHEDULE 13G/A

Filing date

Feb 11, 2026

Accession number

0001999371-26-003032

Filer

Intellia Therapeutics, Inc. (CIK 1652130)